Rachel Mcminn's Net Worth

Rachel Mcminn's net worth is estimated to be at least $1,258,296.38 as of 12/15/2024. CoreStreet's estimation of Rachel Mcminn's net worth is based on their sale of stock and current holding of stock.

Rachel Mcminn is CEO at Neurogene Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 47,500 units of NGNE stock on 11/22/2024. Their biggest sale was on 01/03/2017 when they sold 816 units of Intercept Pharmaceuticals Inc stock for $84,798.72. They typically trade 2 times per year.

Total value of insider buys:
  • $969,000.00
Total value of insider sells:
  • $289,296.38
Most recent insider trade:
  • Nov. 22, 2024

Rachel Mcminn's Insider Trading History

Neurogene IncTitleAmountPriceTypeTotal Value
Nov. 22, 2024
CEO47,500$20.40Buy$969,000.00
Intercept Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Oct. 2, 2017
Insider283$58.89Sell$16,665.87
July 31, 2017
Insider130$123.12Sell$16,005.60
May 1, 2017
Insider114$113.12Sell$12,895.68
Jan. 3, 2017
Insider816$103.92Sell$84,798.72
Oct. 31, 2016
Insider129$123.82Sell$15,972.78
Aug. 1, 2016
Insider125$176.57Sell$22,071.25
May 2, 2016
Insider130$147.49Sell$19,173.70
Feb. 1, 2016
Insider128$103.56Sell$13,255.68
Jan. 4, 2016
Insider469$145.90Sell$68,427.10
Nov. 2, 2015
Insider125$160.24Sell$20,030.00